The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Site-specific disease progression in patients with metastatic renal cell carcinoma treated with first-line nivolumab plus ipilimumab or axitinib-based immunotargeted combinations.
 
Ilya Tsimafeyeu
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono
Speakers' Bureau - BIOCAD; Bristol-Myers Squibb; Merck Serono
 
Fuad Guliyev
No Relationships to Disclose
 
Gunel Musayeva
No Relationships to Disclose
 
Ramil Abdrakhmanov
No Relationships to Disclose
 
Viacheslav Chubenko
No Relationships to Disclose
 
Olga Baklanova
No Relationships to Disclose
 
Ruslan Zukov
No Relationships to Disclose
 
Vladislav Petkau
No Relationships to Disclose
 
Igor Myslevtsev
No Relationships to Disclose
 
Alisher Kahharov
No Relationships to Disclose
 
Bakytzhan Ongarbayev
No Relationships to Disclose
 
Dilyara Kaidarova
No Relationships to Disclose